Brand tirzepatide
Sold by Vytora Health · every brand tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$1,399
| Medication · Mounjaro, month-to-month | $1,399 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Mounjaro, month-to-month “Mounjaro® Name-brand tirzepatide for type 2 diabetes by Eli Lilly $1,399 / month Month-to-month · Prescription required” | Per month$1,399 | Charged today$1,399 |
We earn nothing from this link. Vytora Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | “Vytora Health is a subscription service — your payment method is charged automatically each billing cycle until you cancel. Cancel anytime by emailing support@vytorahealth.com.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from vytorahealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.